New Gastric & Esophageal Cancer Treatment Breakthrough

There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.

Understanding the cellular origin and progression of esophageal

New Gastric & Esophageal Cancer Treatment Breakthrough

Current Oncology, Free Full-Text

Impacts and mechanisms of metabolic reprogramming of tumor

New Targeted Treatments Emerge for Gastric and Esophageal Cancer

Breakthrough in treatment for stomach and esophageal cancer

Gastric cancer treatment: recent progress and future perspectives

Current State of Targeted Therapy and Immunotherapy in Advanced

Updated Treatment of Esophageal cancer, Rapid Clinical Review

Stomach (Gastric) Cancer

Comprehensive study of esophageal cancer reveals several molecular

Global Ring Study to Investigate the Comparability of Total Assay

Esophageal Cancer Market worth $25.99 billion by 2030, growing

Gastric Cancer Foundation In breakthrough, Japanese researchers